MedTrace Logo

Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients

NCT04561895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2020-09-24

No results posted yet for this study

Summary

Due to the limited data concerning Egyptian population. authors aimed to investigate the differentadipokine gene polymorphism related to non alcoholic fatty liver disease incidence, prognosis and progression to steotosis and also to find different related factors including obesitu, diabetes and liver enzymes level

Conditions

  • NAFLD
  • NASH - Nonalcoholic Steatohepatitis

Interventions

GENETIC

DNA extraction

investigation of DNA polymorphism in patients suffering from NAFLD

Sponsors & Collaborators

  • Elsahel teaching hospital

    collaborator UNKNOWN

  • Cairo University

    lead OTHER

Principal Investigators

  • Amal Ahmed, PhD · professor

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-09-15
Completion
2020-09-16

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04561895 on ClinicalTrials.gov